Mononucleosis Diagnostic market report offers one of the best solutions to know the trends and opportunities in Mononucleosis Diagnostic industry. This report offers broader perspective of the market place with its comprehensive market insights and analysis. The Mononucleosis Diagnostic market research report contains lot of features to offer for Mononucleosis Diagnostic industry which includes general market conditions, trends, inclinations, key players, opportunities, and geographical analysis. What is more, this report provides superior market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behavior's.
The Mononucleosis Diagnostic report contains top to bottom analysis and estimation of various market related factors that are incredibly crucial for better decision making. Competitive analysis has been carried out in the Mononucleosis Diagnostic report for the major players in the market, which supports businesses take better moves for enhancing their product and sales. Furthermore, this Mononucleosis Diagnostic research report takes into consideration several industry verticals such as company profile, contact details of players, product specifications, geographical scope, production value, market structures, recent developments, revenue analysis, market shares and possible sales volume of the company.
Data Bridge Market Research analyses that the mononucleosis diagnostic market which is expected to reach at a CAGR of 5.00% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-mononucleosis-diagnostic-market
According to the Centers for Disease Control and Prevention, there were approximately 23,780 incident cases of infectious mononucleosis (IM) between 2002 and 2018, for an overall incidence rate of 104.2 cases per 100,000 person-years (p-yrs). The prevalence of IM diagnoses was highest among the youngest age groups and decreased with age. When compared to other race/ethnicity groups, non-Hispanic white service members had a higher incidence rate of IM diagnoses (123.4 per 100,000 p-yrs). The incidence of IM diagnoses among recruits was 3.4 times that of other enlisted personnel (106.0 per 100,000 p-yrs) and 5.6 times that of officers (64.7 per 100,000 p-yrs). As a result of rising incidences of infectious mononucleosis (IM), the demand for its diagnosis rises, resulting in growth.
Key Growth Drivers:
- Technological advancements act as a promising driver
Various novel technological advancements are occurring that can diagnose the infection faster than available on the market. For instance, Roche announced in 2020 that the USFDA had approved the Cobas EBV test, the first in-vitro quantitative diagnostic test in the US for the diagnosis of EBV Epstein-Barr Virus. This is a huge success for the healthcare industry and professionals because it will make it much easier to monitor patients who are at risk from this virus because it will perform a large number of tests in a short period of time.
- Increasing adolescent population is laying the foundation for expansion
Increasing adolescent population globally is also one of the major factor leading to growth of the market as mononucleosis is most common among teens and adults. More than half of all adolescents globally live in Asia. South Asia has nearly 350 million adolescents than any other region. It is followed by East Asia and the Pacific with over 300 million. The adolescent population of either of these regions dwarfs that of any other region in the world. According to World Health Organization (WHO) report, there are nearly 1.2 billion adolescents (10-19 years old) worldwide. In some countries, adolescents account for a quarter of the population and the number of adolescents is expected to rise through 2050, mainly in low- and middle-income countries (LMICs) where close to 90% of 10- to 19-year-olds live.
The report outlines the involvement of key players, including:
Abbott (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Weizmann Institute of Science (Israel), Biotest AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Genzyme (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), BD (U.S.), DiaSorin Molecular LLC (U.S.), Beckman Coulter, Inc. (U.S.), bioMérieux (France), Siemens (Germany), Sekisui Diagnostics (U.S.), ELITechGroup (France), Cardinal Health (U.S.), Immunostics Inc. (U.S.), Meridian Bioscience (U.S.), Thermo Fischer Scientific Inc. (U.S.)
Key Market Segmentation
Test Type (Epstein Barr Virus (EBV) Antibody Test, Monospot Test, Complete Blood Count Test), End-User (Hospitals, Laboratories, Others)
Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-mononucleosis-diagnostic-market
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-prurigo-nodularis-treatment-market
https://www.databridgemarketresearch.com/reports/global-mens-health-market
https://www.databridgemarketresearch.com/reports/global-adrenocorticotropic-hormone-acth-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)